Product correctly added to cart.

discount label
CYSLTR2 antibody
View 3D

Biosynth logo

CYSLTR2 antibody

Ref. 3D-70R-51051

100µl
469.00 €
Estimated delivery in United States, on Friday 29 Nov 2024

Product Information

Name:
CYSLTR2 antibody
Description:

The CYSLTR2 antibody is a highly specialized monoclonal antibody that targets the hepatocyte growth factor. It is specifically designed to neutralize the effects of this growth factor and has been extensively studied in the field of Life Sciences. This antibody has shown great potential in inhibiting the activity of epidermal growth factor and Angptl3, which are known to play a crucial role in various cellular processes. The CYSLTR2 antibody is available as both polyclonal antibodies and low-molecular-weight dimers, making it suitable for a wide range of applications. Its high affinity for its target makes it an ideal tool for immunoassays and chromatographic techniques. With its exceptional specificity and neutralizing capabilities, the CYSLTR2 antibody is an invaluable asset for researchers in the field of Life Sciences.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-70R-51051 CYSLTR2 antibody

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".